Logo Sequentia

Sequentia Biotech & Biotech Tricopharming Research

Biotech Tricopharming Research (Tricopharming for short) originated in the R&D department of Sequentia Biotech, a biotech company founded in 2013 in Barcelona, Spain. Led by Dr Luis Matías Hernández, it was set up to investigate the use of tricopharming techniques to optimize different medicinal and aromatic plants, starting with Artemisia annua. Following positive results in the lab and in the pilot field studies, in October 2018, Biotech Tricopharming Research the company was founded in order to continue the development and commercialization of this optimized Artemisia annua, named Artennua, and other aromatic and medicinal plants of commercial interest.